Key Takeaways
- Equity flows hit by flagship fund underperformance: Equity QAAUM grew only ~1.7% YoY as the flagship fund’s strategy struggled over the last 1–1.5 years, dragging net sales and SIPs into negative territory.
- Other income masks core pressure: A ₹174 crore mark-to-market gain on international seed capital lifted other income substantially, while other expenses rose to ₹61 crore on IT and legal spends.
- SIP trajectory recovering after April dip: Monthly SIP registrations fell in April industry-wide as investors close accounts in March, but UTI’s numbers recovered to prior levels by May–June.
- International business at an investment-stage loss: UTI International posted a marginal Q1 loss on initial legal and agreement costs; management expects profitability from Q2 onward.
- What to watch next quarter: Whether the flagship fund’s performance stabilizes enough to turn equity net sales positive, the pace of SIP revival from repositioned funds, and the actual Q2 profit delivery from UTI International.
Equity Franchise Stress
- Flagship fund the root cause: The fund’s growth strategy underperformed over 1–1.5 years, creating a sales headwind that compressed overall equity QAAUM growth to ~1.7% YoY.
- SIP engine stalled then restarted: Maximum SIPs were concentrated in the flagship fund, so its underperformance triggered natural redemptions from investors who entered 5–10 years ago. April’s industry-wide SIP dip reversed in May–June, bringing UTI back to earlier levels.
- Net outflows the consequence: Negative net sales in equity funds were driven entirely by the performance issue; management is working with all channel partners and aggressively marketing other products to return to positive territory.
- No distributor revolt: Products remain on the platform for all distributors and banks; management characterized the pressure as a temporary fund-specific headwind, not a structural channel problem.
Rahman: "We are taking this particular issue very seriously. We are continuously reviewing our both sales strategy and even the investment strategy. And I'm quite confident this particular fund, which is having some challenges, is being managed by a very reputed and experienced fund manager, Ajay Tyagi. And therefore, I'm fully confident that it will turn around."
Yield Dynamics
- Equity yield edged up despite outflows: Equity yield improved one basis point (72 to 73 bps) because mark-to-market appreciation on older AUM offset the compression that would normally come from negative net sales.
- International yield drop is mix-driven, not price-driven: Newer funds like UTI India Sovereign Bond and Strategic Opportunities Funds I & II carry lower fees than equity funds, pulling down the blended yield. The Dynamic Equity Fund, if it attracts money, would lift yields meaningfully.
- Modest compression ahead: Management expects yield to compress by a basis point or two over the next 2–3 quarters as the ETF business grows, the new Balanced Advantage Fund NFO scales, and fresh equity inflows (when they resume) come in at current market levels.
- Group margin trajectory tied to mix: Overall group yield is expected to increase as equity funds regain performance and traction, with the mix shift toward higher-fee products driving the improvement.
International Business Build-Out
- Q1 loss was start-up cost: UTI International posted a marginal loss driven by legal fees from signing multiple new agreements; management stated the company will be profitable from Q2 onward and for the full year.
- Revenue run-rate ambition: Management expects a quarterly topline of ₹32–34 crore, though the timeline for achieving this was not specified with precision.
- Product push into Europe and Asia: Plans include distributing the UTI India Innovation Fund in Europe and Asia, expanding reach for the India G-Sec ETF listed on Euronext Amsterdam to European institutional investors, and promoting a balanced fund in the Middle East among NRIs.
- Paris and US offices: The company is foraying into European markets through a Paris office and into the United States, adding distribution infrastructure to capture the India overweight trend.
Rahman: "But this company at the year-end will be profitable in this quarter itself, the Q2 will be profitable."
Alternatives & New Initiatives
- Alternatives rebranded and building: UTI Alternatives Pvt. Ltd. (renamed from UTI Capital) aims to be a multi-asset manager of alternate assets; a real estate credit fund launched in July 2023, and two new funds (investment-grade performing credit and distressed credit) have been filed with SEBI.
- Equity strategies under evaluation: The alternatives platform is finalizing equity strategies to round out its multi-asset ambition; management hopes to reach breakeven this financial year.
- Continued investment committed: The business is fully capitalized with good financial resources allocated; management will continue investing.
- Product factory still running: Five funds launched in Q1 including three index funds and two silver ETFs; the UTI Balanced Advantage Fund NFO is live with all distributors including banks.
- Physical distribution expanding: 29 new UFCs (branch offices) and 6 resident offices planned for FY24, partly substituting for district associate agreements that were not renewed as incumbents retired.
Cost Base & Below-the-Line Items
- Employee costs flat, hiring offset by retirements: Employee expenses held at ₹106 crore for both Q4 FY23 and Q1 FY24; 108 management trainees were recruited to prepare for branch expansion and upcoming retirements, with the cost impact expected to be neutral as retirees leave.
- Other expenses step up to new run-rate: Other expenses rose from ₹49 crore to ₹61 crore YoY, driven by IT initiatives (~₹4.5 crore, with benefits spread across the year), CSR, and legal and strategic expenses. The ₹60–61 crore quarterly run-rate is expected to persist.
- ESOP and variable pay steady: ESOP cost will continue at ₹4 crore per quarter unless fresh grants are issued; variable pay is similar to last year at ₹45 crore standalone and ₹58 crore consolidated.
- Retirement savings a medium-term tailwind: Over the next 3–4 years, most old-grade employees will retire; since all three subsidiaries are fully capitalized, the savings are expected to flow directly to the P&L, though management declined to quantify the benefit.
Rahman: "That is the fair assumption because all our three companies are fully capitalized... and therefore all the benefits will go towards the P&L."
Capital & Cash Position
- No cash distribution planned: Management is seriously evaluating the cash element but has no current plan to distribute it, citing potential future business development needs.
- GIFT City office in the works: A presence in GIFT City is being planned, adding another potential use for retained capital.
Rahman: "We are seriously looking at the cash element, but we have no plan at this particular point of time to distribute the cash. We may need it for our future business development."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Equity net sales | Confident net sales will be positive in equity | No date (implied near-term) |
| Flagship fund turnaround | Fund managed by Ajay Tyagi; sales and investment strategy under continuous review | No date (confidence expressed) |
| UTI International profitability | Profitable from Q2 onward; full-year profitable | Q2 FY24 and FY24 |
| Other expenses run-rate | ₹60–61 crore per quarter | FY24 |
| Employee expenses run-rate | ₹106 crore per quarter | FY24 |
| Alternatives breakeven | Hope to breakeven this financial year | FY24 |
| Yield compression | Slight compression of a basis point or two over next 2–3 quarters | Next 2–3 quarters |
| SIP revival | Positioning other well-performing funds to distribution partners | No date (confidence expressed) |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Consolidated revenue | ₹468 crore, up 56% QoQ and 60% YoY |
| Consolidated net profit | ₹234 crore, growth of 172% QoQ and 154% YoY |
| Standalone PAT | ₹165 crore, growth of 68% QoQ and 67% YoY |
| Group total AUM | ₹16.13 lakh crore as on 30th June 2023, growth of ~16.8% YoY |
| UTI MF quarterly average AUM (QAAUM) | ₹2.48 lakh crore, up ~10.6% YoY |
| UTI MF net sales | ₹10,152 crore for Q1 FY24 |
| Equity QAAUM | ₹72,811 crore, rising ~9.2% YoY |
| Index and ETFs QAAUM | ₹88,431 crore, growth of 35.6% |
| SIP AUM | ₹24,920 crore as of June 2023, growth of 40.1% YoY |
| SIP inflows for the quarter | ₹1,652 crore |
| Average SIP ticket size | ₹3,142 for June 2023 |
| Live SIP folios | 25.16 lakh as of June 2023, up by 20 thousand during the quarter |
| B30 cities contribution to MAAUM | 22% of Monthly Average AUM for June 2023, industry average 17% |
| UTI Retirement Solutions Ltd AUM | ₹2.58 lakh crore, growth of ~27% YoY; manages 26.57% of Industry AUM |
| UTI International Ltd AUM | ₹21,772 crore as of 30th June 2023 |
| UTI Alternatives Pvt. Ltd. total AUM | ₹1,784 crore |
| Employee expenses run rate | ₹106 crore per quarter, flat QoQ |
| Other expenses run rate | ₹60 to 61 crore per quarter |
| Overall equity and hybrid yield | 76-77 basis points |
| Gross equity and hybrid sales | ₹2,344 crore for the quarter |
| Older AUM with negligible trail commission | ~20% of total AUM |
| Cash on books | ₹3,500 crore |
| Consolidated variable pay (full year) | ₹58 crore on consolidated basis, similar to last year |
| ESOP cost for FY24 | ₹16 crore total for FY24, ₹4 crore in Q1 |